INTRAVESICAL NECTIN4 CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER

$630,000FY2024Defense Health AgencyDOD

University Of California, Los Angeles

Investigators

INTRAVESICAL NECTIN4 CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER · GrantIndex